In tumors with low levels of infiltrating Treg cells, administration of IL-33 accelerates tumor growth and occurrence of liver and lung metastasis in breast cancer mouse models, and these models display an intratumoral accumulation of MDSC and Treg cells, as compared to untreated mice (90). This evidence concerns the gene IL33 and breast carcinoma.